Fig. 10From: RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signaturesLog2 read counts of therapeutically relevant RTK genes, PI3K isoforms, and downstream molecules in the PI3K-Akt signaling pathway, as well as claudin genes 1, 3, 4 and 7, and the therapeutic target PTGS2. Cell lines were depicted as triangles, compared with averaged log2 read counts of all tissues of the same histopathological classification, represented as gray columnsBack to article page